SOURCE: ALR Technologies

August 01, 2011 18:01 ET

Reimbursement for Endocrinologists Using ALRT Health-e-Connect (HeC) System for Intensive Blood Glucose Control in British Columbia, Canada

ATLANTA, GA--(Marketwire - Aug 1, 2011) - ALR Technologies Inc. (OTCBB: ALRT) announces that British Columbia Medical Services Plan published a schedule to include reimbursement to endocrinology specialists for several virtual services with patients in June, 2011. Information on the new reimbursement can be viewed at:

http://www.health.gov.bc.ca/msp/infoprac/physbilling/payschedule/pdf/42.%20specialist-services-committee-initiated-listings.pdf.

The British Columbia Medical Services Plan is the single payer provider of medical services in the Province of British Columbia, Canada. It has over 4.4 million lives in its system with more than 200,000 diabetes patients.

ALRT also recently announced the results of a 12 month clinical trial using the ALRT HeC System as an Internet Based Blood Glucose Monitoring System (IBGMS) to provide intensive blood glucose control. The clinical trial was headed by Dr. Hugh Tildesley, a leading Canadian endocrinologist and was conducted in British Columbia. It was published in the July issue of the Canadian Journal of Diabetes. The study concluded that, "the continuous use of an IBGMS is an effective method of improving glucose control compared to standard care." The article also pointed out that "the absence of a payment model to reimburse out-of-office consultations" as a limitation.

The ALRT HeC system can be used by endocrinologists in British Columbia, Canada to provide intensive blood glucose control and they will be reimbursed under the new virtual services codes. ALRT plans to register with Health Canada in preparation for sales.

"Starting to pay doctors for remote care by the British Columbia Medical Services is a great first step forward in telemedicine," said Sidney Chan, Chairman and CEO of ALR Technologies. "We plan to work with partners to demonstrate that using an IBGMS like the ALRT HeC System for intensive blood glucose control by qualified healthcare providers is efficient, will improve health outcomes and will result in substantial cost savings."

"Success of the British Columbia initiative should prompt other provincial medical plans and payers to follow suit. Reimbursement will need to include the cost of IBGMS."

Mr. Chan also states; "There is a growing shortage of endocrinologists(1). With the ever increasing population of patients with diabetes, the HeC system can become an essential tool for healthcare providers to deliver quality and efficient care to the millions of patients."

About ALR Technologies Inc.
ALRT Health-e-Connect (HeC) System is the principal product of the Company. HeC is a web based patient management platform for medical professionals to improve compliance and adherence of care plans of patients in their homes. HeC is programmed to assist healthcare providers caring for diabetes patients. The platform will be expanded to cover patients with other chronic diseases. The HeC System is not available for sale in the US pending FDA 510(k) clearance. More information on ALR Technologies and its products can be found at http://www.alrt.com.

This release contains certain "forward-looking statements" relating to ALR Technologies' business, and these statements reflect the current views of ALR Technologies with respect to future events and are subject to certain risks, uncertainties and assumptions. When used, the words "estimate", "expect", "anticipate", "believe" and similar expressions are intended to identify such forward-looking statements. There are many factors that could cause the actual results, performance or achievements of ALR Technologies and its products to be materially different from any future results, performances or achievements that may be expressed or implied by such forward-looking statements. Further management discussions of risks and uncertainties can be found in the company's quarterly filings with the Securities Exchange Commission.

(1) http://www.endocrinetoday.com/view.aspx?rid=83667

Contact Information